Multi-Drug Resistant Nephrotic Syndrome Clinical Trials

7 clinical trials for Multi-Drug Resistant Nephrotic Syndrome across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease — RECRUITING · PHASE1
• Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease — RECRUITING · PHASE1
• CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease — RECRUITING · PHASE1
• Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease — RECRUITING · PHASE1
• Study of Therapeutic Efficacy of CAR-T Cell Therapy in Patients With MDR-SRNS — RECRUITING · PHASE1
• RD06-05 Universal CD19/BCMA CAR-T for Refractory Pediatric Autoimmune Diseases — NOT_YET_RECRUITING · PHASE1
• Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cell Therapy in Patients With MDR-SRNS — WITHDRAWN · PHASE1

Refine this search